Ginkgo Bioworks Holdings, Inc. (DNA)

USD 8.36

(2.96%)

Operating Income Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual operating income in 2023 was -864.4 Million USD , up 69.57% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly operating income in 2024 Q1 was -158.73 Million USD , down -2.77% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported an annual operating income of -2.2 Billion USD in 2022, down -20.81% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported an annual operating income of -1.82 Billion USD in 2021, down -1234.38% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly operating income of -150.53 Million USD for 2024 Q2, down -40.45% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly operating income of -286.39 Million USD for 2023 Q3, down -55.52% from previous quarter.

Annual Operating Income Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Operating Income of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Operating Income Operating Income Growth
2023 -864.4 Million USD 69.57%
2022 -2.2 Billion USD -20.81%
2021 -1.82 Billion USD -1234.38%
2020 -137.02 Million USD -91.38%
2019 -71.59 Million USD 0.0%
2001 -234.5 Million USD 0.0%

Peer Operating Income Comparison of Ginkgo Bioworks Holdings, Inc.

Name Operating Income Operating Income Difference
ADC Therapeutics SA -165.98 Million USD -420.77%
Alto Neuroscience, Inc. -37.8 Million USD -2186.244%
Annovis Bio, Inc. -45.03 Million USD -1819.409%
Biohaven Pharmaceutical Holding Company Ltd. -436.05 Million USD -98.235%
Nuvation Bio Inc. -99.82 Million USD -765.947%
Nuvation Bio Inc. -99.82 Million USD -765.947%
Arcus Biosciences, Inc. -340 Million USD -154.237%
Zymeworks Inc. -138.05 Million USD -526.141%